Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua
Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua

China approves mixed-use Covid-19 vaccine trials to start in autumn

  • US firm Inovio’s DNA vaccine to be combined with Sinovac in bid to achieve a stronger immune response
  • Sinovac is also reporting an increase in antibody levels after a third booster shot of its vaccine

Topic |   Coronavirus pandemic
Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua
Chinese-made Covid-19 vaccine Sinovac will be combined with a DNA vaccine developed by US firm Inovio in clinical trials to take place in China. Photo: Xinhua
READ FULL ARTICLE